These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34337729)

  • 21. D-Chiro-inositol and PCOS: between myth and reality. The never-ending story.
    Cianci A; Vitale SG
    Int J Food Sci Nutr; 2022 Aug; 73(5):565-570. PubMed ID: 35057707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study.
    Troisi J; Cinque C; Giugliano L; Symes S; Richards S; Adair D; Cavallo P; Sarno L; Scala G; Caiazza M; Guida M
    J Ovarian Res; 2019 Mar; 12(1):25. PubMed ID: 30904021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study.
    Advani K; Batra M; Tajpuriya S; Gupta R; Saraswat A; Nagar HD; Makwana L; Kshirsagar S; Kaul P; Ghosh AK; Pradhan S; Mehta A; Jaiswal A; Nakhate KT; Kamdi S
    J Obstet Gynaecol; 2020 Jan; 40(1):96-101. PubMed ID: 31339394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review.
    Galazis N; Galazi M; Atiomo W
    Gynecol Endocrinol; 2011 Apr; 27(4):256-62. PubMed ID: 21142777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myo-inositol vs. D-chiro inositol in PCOS treatment.
    Formuso C; Stracquadanio M; Ciotta L
    Minerva Ginecol; 2015 Aug; 67(4):321-5. PubMed ID: 25670222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review.
    Iervolino M; Lepore E; Forte G; Laganà AS; Buzzaccarini G; Unfer V
    Nutrients; 2021 May; 13(5):. PubMed ID: 34063339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of myo-inositol/di-chiro-inositol on markers of ovarian reserve in women with PCOS undergoing IVF/ICSI: A systematic review and meta-analysis.
    Bhide P; Pundir J; Gudi A; Shah A; Homburg R; Acharya G
    Acta Obstet Gynecol Scand; 2019 Oct; 98(10):1235-1244. PubMed ID: 30993683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inositol Restores Appropriate Steroidogenesis in PCOS Ovaries Both In Vitro and In Vivo Experimental Mouse Models.
    Fedeli V; Unfer V; Dinicola S; Laganà AS; Canipari R; Monti N; Querqui A; Galante E; Laurenzi G; Bizzarri M
    Cells; 2024 Jul; 13(14):. PubMed ID: 39056753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS).
    Fruzzetti F; Perini D; Russo M; Bucci F; Gadducci A
    Gynecol Endocrinol; 2017 Jan; 33(1):39-42. PubMed ID: 27808588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome.
    Dinicola S; Chiu TT; Unfer V; Carlomagno G; Bizzarri M
    J Clin Pharmacol; 2014 Oct; 54(10):1079-92. PubMed ID: 25042908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.
    Minozzi M; Nordio M; Pajalich R
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):537-40. PubMed ID: 23467955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both.
    Genazzani AD; Prati A; Marchini F; Petrillo T; Napolitano A; Simoncini T
    Gynecol Endocrinol; 2019 Dec; 35(12):1088-1093. PubMed ID: 31304823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients.
    Genazzani AD; Prati A; Santagni S; Ricchieri F; Chierchia E; Rattighieri E; Campedelli A; Simoncini T; Artini PG
    Gynecol Endocrinol; 2012 Dec; 28(12):969-73. PubMed ID: 22612517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.
    Pizzo A; Laganà AS; Barbaro L
    Gynecol Endocrinol; 2014 Mar; 30(3):205-8. PubMed ID: 24351072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance.
    Kamenov Z; Kolarov G; Gateva A; Carlomagno G; Genazzani AD
    Gynecol Endocrinol; 2015 Feb; 31(2):131-5. PubMed ID: 25259724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
    Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
    J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA).
    Cirillo F; Catellani C; Lazzeroni P; Sartori C; Tridenti G; Vezzani C; Fulghesu AM; Madeddu E; Amarri S; Street ME
    Gynecol Endocrinol; 2020 Jul; 36(7):588-593. PubMed ID: 32054355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of the treatment with D-chiro-inositol on levels of oxidative stress in PCOS patients].
    De Leo V; La Marca A; Cappelli V; Stendardi A; Focarelli R; Musacchio MC; Piomboni P
    Minerva Ginecol; 2012 Dec; 64(6):531-8. PubMed ID: 23232537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myo-inositol in assisted reproductive technology from bench to bedside.
    Etrusco A; Laganà AS; Chiantera V; Buzzaccarini G; Unfer V
    Trends Endocrinol Metab; 2024 Jan; 35(1):74-83. PubMed ID: 37798243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.